ADHD Initiation Checklist for Prescribers: A Practical, Safe, and Evidence-Based Guide

Starting medication for ADHD is one of the most impactful interventions in mental health care—but it carries responsibility. A structured initiation process helps ensure safety, optimise outcomes, and build patient trust from the outset.

Whether you’re an independent prescriber, nurse practitioner, or part of a specialist ADHD service, having a clear checklist reduces risk and improves consistency.

This guide walks through a comprehensive ADHD initiation checklist for prescribers, covering assessment, baseline screening, medication selection, and follow-up—aligned with best practices in UK-based care.

Why a Structured ADHD Initiation Process Matters

ADHD medications—particularly stimulants like methylphenidate and lisdexamfetamine—are highly effective, but not risk-free.

A structured initiation ensures:

• Accurate diagnosis before prescribing

• Identification of contraindications

• Safe baseline physical health checks

• Appropriate medication selection

• Clear patient education and expectations

• Ongoing monitoring and titration

Without this, you risk misdiagnosis, adverse effects, or poor adherence.

Think of it like building a house—you wouldn’t start laying bricks without checking the foundation.

ADHD Initiation Checklist for Prescribers

1. Confirm a Robust ADHD Diagnosis

Before prescribing, ensure diagnostic clarity.

• Use DSM-5 or ICD-11 criteria

• Confirm symptom presence in multiple settings

• Establish childhood onset (or strong developmental history)

• Assess functional impairment (work, education, relationships)

• Rule out alternative explanations (e.g. anxiety, depression, trauma, sleep disorders)

• Screen for comorbidities (common ones include ASD, anxiety, substance use)

Clinical tip: Many prescribing risks stem from weak diagnostic processes—not medication itself.

2. Conduct a Full Medical and Psychiatric History

This step identifies risks and contraindications.

• Cardiovascular history (hypertension, arrhythmias, structural disease)

• Family history of sudden cardiac death

• Current medications (including SSRIs, antipsychotics, recreational drugs)

• Substance misuse history

• Psychiatric comorbidities (especially bipolar disorder or psychosis)

• Sleep patterns and baseline functioning

Red flags to pause prescribing:

• Uncontrolled hypertension

• Active substance misuse

• Suspected bipolar disorder without stabilisation

• Significant cardiac history

3. Baseline Physical Observations

Essential before starting stimulant medication:

• Blood pressure

• Heart rate

• Weight

• Height (especially in children/young adults)

• BMI

If abnormalities are detected:

• Consider GP or cardiology input

• Do not initiate until risk is clarified

Optional but sometimes indicated:

• ECG (if cardiac history present)

4. Risk Assessment and Safeguarding

• Assess suicide risk

• Evaluate impulsivity and risk-taking behaviour

• Consider safeguarding concerns (especially in younger patients)

This isn’t just a formality—ADHD can overlap with emotional dysregulation and risk behaviours.

5. Patient Education and Informed Consent

This step is often rushed—but it’s crucial.

Discuss:

• How ADHD medication works

• Expected benefits (focus, impulsivity, executive function)

• Common side effects (appetite loss, insomnia, headaches)

• Rare but serious risks (cardiovascular, mood changes)

• Titration process and timeline

• Importance of adherence

• Driving and legal considerations (UK DVLA guidance if relevant)

Document informed consent clearly.

6. Choose the Right Medication

First-line options (UK guidance aligned):

• Methylphenidate (e.g. Medikinet, Concerta)

• Lisdexamfetamine (Elvanse)

Consider:

• Patient lifestyle (duration of action needed)

• Side effect profile

• Previous medication trials

• Risk of misuse/diversion

Example decision-making:

• Short working day → immediate-release methylphenidate

• Full-day coverage → modified-release or lisdexamfetamine

7. Start Low, Titrate Gradually

Key principle: Start low, go slow.

Typical approach:

• Begin at lowest effective dose

• Increase every 1–2 weeks

• Monitor response and side effects

• Aim for optimal balance—not maximum dose

Avoid:

• Rapid dose escalation

• Ignoring side effects

• Over-reliance on patient self-adjustment

8. Set Up a Monitoring Plan

Monitoring is where many services fall short.

At each follow-up:

• Blood pressure and heart rate

• Weight

• Symptom improvement

• Side effects

• Adherence

Frequency:

• Every 2–4 weeks during titration

• Every 3–6 months once stable

Use structured rating scales where possible (e.g. ASRS).

9. Document Everything Clearly

Good documentation protects both patient and prescriber.

Include:

• Diagnostic rationale

• Risk assessment

• Baseline observations

• Consent discussion

• Medication choice reasoning

• Monitoring plan

If it’s not documented, it didn’t happen.

10. Plan for Long-Term Care

ADHD treatment is ongoing—not a one-off prescription.

• Annual medication review

• Ongoing physical health monitoring

• Reassessment of need

• Consider non-pharmacological support (CBT, coaching)

Common Mistakes Prescribers Should Avoid

• Starting medication without a full diagnostic assessment

• Skipping cardiovascular screening

• Poor patient education

• Inadequate follow-up during titration

• Ignoring comorbid conditions

• Overprescribing without monitoring

These are not just clinical risks—they also impact patient trust and outcomes.

How a Structured ADHD Service Improves Outcomes

For independent prescribers and clinics, having a clear initiation protocol:

• Improves patient safety

• Enhances clinical confidence

• Standardises care delivery

• Builds credibility and trust

• Reduces medico-legal risk

It also becomes a strong differentiator in a crowded ADHD service market.

FAQs: ADHD Initiation for Prescribers

What checks are required before starting ADHD medication?

At minimum:

• Full diagnostic assessment

• Cardiovascular history

• Blood pressure and heart rate

• Weight and BMI

• Psychiatric and substance use history

Additional checks (like ECG) depend on clinical risk.

Do all patients need an ECG before starting stimulants?

No. ECG is not routinely required unless there is:

• Personal cardiac history

• Family history of sudden cardiac death

• Abnormal cardiovascular findings

What is the first-line ADHD medication in adults?

Typically:

• Methylphenidate or lisdexamfetamine

Choice depends on patient response, side effects, and lifestyle needs.

How often should patients be monitored during titration?

• Every 2–4 weeks

This allows dose adjustment and early detection of side effects.

What are the most common side effects?

• Reduced appetite

• Insomnia

• Dry mouth

• Headaches

• Increased heart rate

Most are mild and manageable.

When should you avoid prescribing stimulants?

Avoid or delay if:

• Uncontrolled hypertension

• Active substance misuse

• Untreated bipolar disorder

• Significant cardiac risk

Can ADHD medication be stopped?

Yes. Regular review is important, and medication can be paused or stopped if:

• Symptoms improve

• Side effects outweigh benefits

• Patient preference changes

If you’re building or refining your ADHD prescribing service, having clear systems in place is essential.

At Focus Gently, we’re developing structured, patient-centred ADHD care pathways that prioritise safety, clarity, and outcomes.

Explore more resources, tools, and guidance here.